Tags

Type your tag names separated by a space and hit enter

Effects of ethanolamine (Etn) administration on Etn and choline (Ch) levels in plasma, brain extracellular fluid (ECF) and brain tissue, and on brain phospholipid levels in rats: an in vivo study.
Neurosci Res Commun. 1996 Mar-Apr; 18(2):87-96.NR

Abstract

The sources and fates of brain ethanolamine (Etn) are poorly known and the effects of its administration have not been investigated, even though cortical levels are known to be reduced in certain neurodegenerative diseases. We studied the effect of different Etn doses (10(-3), 5 x 10(-3) and 10(-2) mol/kg, i. p.) on its and choline's (Ch) levels in arterial plasma and brain extracellular fluid (ECF) of awake rats. We also studied its effects on brain levels of Etn, Ch, and their respective major phospholipids. Etn administration caused dose dependent increases in Etn levels within both plasma and brain ECF. For the 10(-2) mol/kg dose, Etn levels were significantly (p<0.01) greater than pre-injection values in both the plasma and ECF. Whole brain Etn and phosphatidylethanolamine were also significantly (p<0.05) increased by 10(-2) mol/kg Etn. Exogenous Etn significantly (p<0.05) increased Ch levels in plasma and whole brain; Etn also increased brain ECF Ch levels. Our data show for the first time that circulating Etn can act as a source of brain Ch. Metabolic pathways that might mediate the increases in Etn and Ch are discussed, as are possible mechanisms of the decreases in brain Eth seen in Alzheimer's disease.

Links

patent databases

Authors+Show Affiliations

Marshall DL
Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge 02139-4307, USA.
De Micheli E
No affiliation info available
Bogdanov MB
No affiliation info available
Wurtman RJ
No affiliation info available

MeSH

Alzheimer DiseaseAnimalsBrainCholineDose-Response Relationship, DrugEthanolamineEthanolaminesExtracellular SpaceMaleMembrane LipidsPhosphatidylcholinesPhosphatidylethanolaminesPhospholipidsRatsRats, Sprague-Dawley

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

Language

eng

PubMed ID

11540106

Citation

Marshall, D L., et al. "Effects of Ethanolamine (Etn) Administration On Etn and Choline (Ch) Levels in Plasma, Brain Extracellular Fluid (ECF) and Brain Tissue, and On Brain Phospholipid Levels in Rats: an in Vivo Study." Neuroscience Research Communications, vol. 18, no. 2, 1996, pp. 87-96.
Marshall DL, De Micheli E, Bogdanov MB, et al. Effects of ethanolamine (Etn) administration on Etn and choline (Ch) levels in plasma, brain extracellular fluid (ECF) and brain tissue, and on brain phospholipid levels in rats: an in vivo study. Neurosci Res Commun. 1996;18(2):87-96.
Marshall, D. L., De Micheli, E., Bogdanov, M. B., & Wurtman, R. J. (1996). Effects of ethanolamine (Etn) administration on Etn and choline (Ch) levels in plasma, brain extracellular fluid (ECF) and brain tissue, and on brain phospholipid levels in rats: an in vivo study. Neuroscience Research Communications, 18(2), 87-96.
Marshall DL, et al. Effects of Ethanolamine (Etn) Administration On Etn and Choline (Ch) Levels in Plasma, Brain Extracellular Fluid (ECF) and Brain Tissue, and On Brain Phospholipid Levels in Rats: an in Vivo Study. Neurosci Res Commun. 1996 Mar-Apr;18(2):87-96. PubMed PMID: 11540106.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Effects of ethanolamine (Etn) administration on Etn and choline (Ch) levels in plasma, brain extracellular fluid (ECF) and brain tissue, and on brain phospholipid levels in rats: an in vivo study. AU - Marshall,D L, AU - De Micheli,E, AU - Bogdanov,M B, AU - Wurtman,R J, PY - 1996/3/1/pubmed PY - 2001/9/11/medline PY - 1996/3/1/entrez SP - 87 EP - 96 JF - Neuroscience research communications JO - Neurosci Res Commun VL - 18 IS - 2 N2 - The sources and fates of brain ethanolamine (Etn) are poorly known and the effects of its administration have not been investigated, even though cortical levels are known to be reduced in certain neurodegenerative diseases. We studied the effect of different Etn doses (10(-3), 5 x 10(-3) and 10(-2) mol/kg, i. p.) on its and choline's (Ch) levels in arterial plasma and brain extracellular fluid (ECF) of awake rats. We also studied its effects on brain levels of Etn, Ch, and their respective major phospholipids. Etn administration caused dose dependent increases in Etn levels within both plasma and brain ECF. For the 10(-2) mol/kg dose, Etn levels were significantly (p<0.01) greater than pre-injection values in both the plasma and ECF. Whole brain Etn and phosphatidylethanolamine were also significantly (p<0.05) increased by 10(-2) mol/kg Etn. Exogenous Etn significantly (p<0.05) increased Ch levels in plasma and whole brain; Etn also increased brain ECF Ch levels. Our data show for the first time that circulating Etn can act as a source of brain Ch. Metabolic pathways that might mediate the increases in Etn and Ch are discussed, as are possible mechanisms of the decreases in brain Eth seen in Alzheimer's disease. SN - 0893-6609 UR - https://www.unboundmedicine.com/medline/citation/11540106/Effects_of_ethanolamine__Etn__administration_on_Etn_and_choline__Ch__levels_in_plasma_brain_extracellular_fluid__ECF__and_brain_tissue_and_on_brain_phospholipid_levels_in_rats:_an_in_vivo_study_ L2 - https://medlineplus.gov/alzheimersdisease.html DB - PRIME DP - Unbound Medicine ER -